wm, westmead hospital, sydney, australia wieland meyer phd molecular mycology laboratory westmead...
TRANSCRIPT
WM, Westmead Hospital, Sydney, Australia
Wieland Meyer PhD
Molecular Mycology LaboratoryWestmead Hospital/The University of Sydney
Molecular Techniques for the Identification of
Pathogenic Fungi
WM, Westmead Hospital, Sydney, Australia
Issues in Mycology Significant increase opportunistic fungal infections due to the
increase in immunocompromised hosts
Cosmopolitan environmental fungi have emerged as causes of potentially life-threatening diseases
Many emerging pathogenic fungi are inherently resistant to antifungal drugs
A number of pathogenic fungi are non-viable in tissue samples Traditional identification techniques lack sensitivity & specificity, are
slow, labor-intensive and require skilled personnel
Clinical and economic consequences
WM, Westmead Hospital, Sydney, Australia
Conventional Fungal Identification Techniques
Identification Method Concerns
Culture ID - only in 26% positive if < 1cfu/ml blood
Serological Tests - limited value (e.g. Iatron Crypto Kit)
- suboptimal sensitivity & specificity
Germ-tube Formation - useful screening test only for C. albicans
(does not differentiate C. dubliniensis)
Carbohydrate Assimilation - limited species in the databases
(e.g. Vitek & API strips) - can misidentify certain pathogenic species
Morphological Characters - subjective measure,
- high degree of skills required
WM, Westmead Hospital, Sydney, Australia
Fungal Identification is Currently Based on the Analysis of:
Morphological Characters Culture and Microscopy
Physiological/Biochemical Characters e.g. Vitek and API
These techniques are often time-consuming, labour intensive and difficult to interpret.
WM, Westmead Hospital, Sydney, Australia
Results Obtained with Vitek-YBC and API
Vitek-YBC API ID32C
Total number of isolates tested 81 80
# of isolates included in the database 55 69
# of isolates correctly identified 48 (87.3%) 50 (76.8%)
# of isolates incorrectly identified 7 (12.7%) 16 (23.2%)
WM, Westmead Hospital, Sydney, Australia
Culture-ID Blood cultures positive in only 20-58% of Invasive
Candidaisis Only in 26% positive if < 1cfu/ml blood, and 10% of Aspergillosis
Serological Tests e.g.:Iatron Cryptococcus Kit
95% accurate with Cryptococcus neoformans
Serotype specific antisera, problems AD strains
Iatron Candida Check Kit
95% accurate with Candida specific antisera
In general suboptimal sensitivity and specificity
WM, Westmead Hospital, Sydney, Australia
Ideal ID/Diagnostic Test
- Sensitive and specific
- High positive predictive value
- High negative predictive value
- Useful for monitoring
- Simple, rapid and inexpensive
WM, Westmead Hospital, Sydney, Australia
Why ?Confirmation of medical diagnosis, choice of therapy, follow-up and prevention are critical to a successful infectious disease management.
- Facilitate earlier diagnosis
- Initiating earlier intervention with aggressive
antifungal treatment to improve patient outcome
- Reduce empiric use of antifungal agents
How ?- Detection of fungal genomic sequences
WM, Westmead Hospital, Sydney, Australia
Why Molecular Methods?
Phenotypic Characters are unstable and can change with environmental changes
Identification methods based on Genotypic Characteristics would be
advantageous and potentially more accurate, reproducible, simple and rapid
WM, Westmead Hospital, Sydney, Australia
Proposed Applications of DNA Protocols
Organism detection in blood
Organism detection in body fluids
Organism detection in tissue
Identification of the fungal agent
Quantification of the fungal load
Monitoring of antifungal treatment
Molecular ID
WM, Westmead Hospital, Sydney, Australia
DNA Technology
DNA probes– Southern Hybridization– In-situ Hybridization– Microarray– Macroarray– Reversed line blot
PCR primers– SSCP– Genotyping– Panfungal PCR– Multiplex PCR– Nested PCR– Real Time PCR– Sequencing– PCR Fingerprinting– AFLP– PCR-RFLP
Karyotyping
WM, Westmead Hospital, Sydney, Australia
Samples used: Blood:Should be collected in tubes containing EDTA (1mg/ml)
!! To not use heparin as anticoagulant !!
Biopsy Tissue:
!! Fresh tissue is always better !!
Paraffin embedded tissue is not always amenable to PCR amplification because of DNA modification due to cross-linking induced by the
fixative or fixation time!
In addition time-dependent physical degradation of DNA in paraffin-embedded tissue limits the length of the DNA fragment amplified.
WM, Westmead Hospital, Sydney, Australia
Targets for PCR, PCR-RFLP, Sequencing& In-situ Hybridization:
Universal fungal primers for:- Multi-copy Genes
rDNA gene cluster 18S, ITS1/2, 5.8S, 28S, 5S, IGS
- Single-copy Genes Actin, Alkaline Protease (ALP), Chitin Synthase,GP43, Lanosterol - - demethylase (LIA1), URA5, Secreted Aspartic Protease (SAP), Beta glucan synthetase (FKS), Histone, etc.
Genus- or species-specific primers 18S, ITS1/2, 28S rDNA, Mitochondrial DNA, Histone
e.g. Candida, Cryptococcus, Aspergillus
WM, Westmead Hospital, Sydney, Australia
Tandem Repeat of the Ribosomal Gene Cluster
Vilgalis Lab, Duke University, NC, USA
WM, Westmead Hospital, Sydney, Australia
1 = Cryptococcus neoformans
2 = Cryptococcus albidus
3 = Candida albicans
Mitchell et al. JCM 1994 32(1) 253-255
Species-Specific Amplification
WM, Westmead Hospital, Sydney, Australia
PCR Amplification of Specific Genes
Clinical specimen Direct PCR of a single colony
form a primary isolation plate, tissue sample or clean culture
Agarose gel electrophoresis ID via comparison with the
data base
Species Level
ITS1, 5.8S, ITS2 region
Nicolas Latouche
WM, Westmead Hospital, Sydney, Australia
Commercial Fungal Molecular Identification Kits
Fungal ID Kits for:
- Blastomyces dermatitidis
- Coccidioides immitis
- Histoplasma capsulatum
- Single-stranded DNA probe targeted to the ribosomal RNA
- Selection reagent differentiates between non-hybridized and hybridized probe
- Labelled DNA:RNA hybrids measured in a GEN-PROBE luminometer
WM, Westmead Hospital, Sydney, Australia
Protocol of the Kits
WM, Westmead Hospital, Sydney, Australia
Histone H3/H4 gene pair is arranged differently between yeast and humans
H3 H4
H3 H4
yeast
Human
MicroBioGenPrimers designed to amplify yeast H3-H4 region should not amplify human sequences
• Four members of histone gene family: H2A, H2B, H3, and H4• The genes are organized into two pairs of genes separated by divergent promoter regions• Histone genes are very highly conserved between species
Highly conserved coding region
Unique species-specific sequence
Highly conserved coding region
Product of amplification using Histone loci
WM, Westmead Hospital, Sydney, Australia
S. cerevisiae cellsS. cerevisiae ID
Z. rouxii ID
K. m
arxianus ID
MicroBioGen
Nested PCR Histone locus
•use degenerate consensus primers to amplify unknown
•use species specific primers to do nested amplification
•use SYBR green to detect PCR product
WM, Westmead Hospital, Sydney, Australia
PCR-RFLP(Restriction Fragment Length Polymorphism Analysis)
Clinical specimen Direct PCR of a single colony
form a primary isolation plate, tissue sample, or clean culture
Agarose gel electrophoresis Digestion with restriction
enzymes Agarose gel electrophoresis ID via comparison with the data
base
Species Level ITS1, 5.8S, ITS2 region
Nicolas Latouche
WM, Westmead Hospital, Sydney, Australia
RFLP MAPSCandida albicans/dubliniensis
“Atlas of Clinical Fungi” 2nd Edition 2000by: GS de Hoog, J Guarro, J Gené & MJ Figueras
Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands
BioloMICS at: www.cbs.knaw.nl
by: V. Robert
Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands and BioAware, Belgium
Atlas of Clinical Fungi de Hoog et al 2000
RFLP maps available from:
WM, Westmead Hospital, Sydney, Australia
Real Time PCR
ABI 7700 System (TaqMan) Reporter Dye and Quencher Probe Detection
Quantitative DNA and Species Detection e.g. Candida sp. detection Guiver et al. J. Clin. Pathol. 2001 54:362-366
Roche LightCycler SYBR Green Detection
Quantitative DNA Detectione.g. Pneumocystis carinii detection Kaiser et al. (2001) J. Microbiol. Meth. 45:113-118
Hybridization Probes (Donor Fluor and Acceptor Fluor) Detection
Quantitative DNA and Species Detection
e.g. C. albicans and A. fumigatus detection Loeffler et al. (2000) JCM 38:586-590
Diagnostics
WM, Westmead Hospital, Sydney, Australia
LightCycler Candida Kit MGRADE
All necessary reagents for amplification and detection of Candida albicans
Targets the ITS region Wide range of biological specimens including swabs,
sputum, urine as well as blood cultures and isolated colonies
Detect Candida albicans in less than 3 hours using the PCR workflow system
Runs under a common thermal profile with other Microbiology specific kits eg. Enterococcus, Pseudomonas and Staphylococcus kits
Diagnostics
WM, Westmead Hospital, Sydney, Australia
PCR-FingerprintingRAPD (Random Amplified Polymorphic DNA)
AFLP (Amplified Fragment Length Polymorphism)
Clinical specimen Pure culture DNA extraction PCR amplification with Mini- or Microsatellite specific primers Agarose gel electrophoresis ID via comparison with the data bank
Species and Strain LevelHomology
Primer Intra-species Inter-speciesM13 75-95% 5-25%
(GACA)4 74-94% 6-26%
(Data obtained from 80 Candida species and 150 strains)
Multilocus approaches:
Meyer et al. (1997) Electrophoresis, 18: 1548-1559
Primer: M13
WM, Westmead Hospital, Sydney, Australia
PCR Fingerprinting Database Development
DNA extraction, PCR fingerprinting and gel running conditions standardized
Reference profiles - 70 anamorph-teleomorph pairs
- type cultures and clinical strains (>300 individual strains)
Pattern analysis via GelcomparII and
Integrated database/web access via
Collaboration is welcome: [email protected]
Heide-Marie Daniel/Krystyna Marszewska/Vincent Robert
WM, Westmead Hospital, Sydney, Australia
Fungal ID via Sequencing Clinical specimen Direct PCR of a single colony from a primary isolation plate,
tissue sample or clean culture DNA extraction PCR amplification Sequencing ID via comparison with the EMBL or GenBank data bases
Species and Strain Level
WM, Westmead Hospital, Sydney, Australia
rDNA gene cluster
18S rDNA or SSU 5.8S rDNA 28S rDNA or LSU 1800 bp 159 bp 3396 bp
IGS ITS 1 ITS 2 IGS 361 bp 231 bp
D1 D2 D3 D4/5 D6/7a/7b D8 D9/10 D11/12 V1/2 V3/4 V5 V7 V8 V9
SR1R SR6R/ITS1
5.8S/ITS2
ITS3 LR1/ITS4
LROR LR12LR16
ITS1
ITS2
LSU
5.8S
SSU
Sequence variability
Discriminatory power
ITS1
ITS2
5.8S
LSU
SSU
Heide-Marie Daniel/Wieland Meyer
WM, Westmead Hospital, Sydney, Australia
Sequence Data Bases EMBL at: www.ebi.ac.uk
GenBank at: www.psc.edu/general/software/packages/genbank/genbank.html
BioloMICS at: www.cbs.knaw.nl
International European rRNA database (Candida)at: www.rrna.uia.ac.be.Isu
Sequence variation used for fungal ID
Sequence Analysis: LSU rDNA PLB1 URA5 Intra-species variation: 0 - 0.5% 0 - 0.8% 0 - 0.3% Inter-species variation: 0 - 17.5% 0.8 - 16% 0.8 - 15%
(Data obtained from sequences of 82 Candida species)
Heide-Marie Daniel/Nicolas Latouche/Stuart Jackson
WM, Westmead Hospital, Sydney, Australia
Not all
fungal species
are
sequenced!!!
Candida species 18S ITS1 ITS2 28S
Candida castelii Y
Candida catenulata Y Y
Candida ciferri Y
Candida famata var.famata Y Y Y Y
Candida famata var. flareri Y Y Y Y
Candida (Torulopsis) glabrata Y Y Y Y
Candida guilliermondiiCandida humicola Y Y
Candida inconspicua Y
Candida intemedia Y
Candida kefyr Y
Candida krusei Y Y Y Y
Candida lambica Y Y
Candida lipolytica Y Y
Candida lusitaniae Y Y Y Y
Candida nitrativoransCandida norvegenisis Y Y
Candida norvegica Y
Candida parapsilosis Y Y Y Y
Candida (Torulopsis) pintolopesii Y Y Y Y
Candida pseudotropicalisCandida pulcherrima Y Y
Candida rugosa (var rugosa)Candida saitoana Y Y
Candida sake Y Y
Candida sphaericaCandida utilisCandida validaCandida viswanathii Y Y Y
Candida zeylanoides Y Y Y
Candida lusitaniae Y Y
e.g. GenBank 1.10.2002
WM, Westmead Hospital, Sydney, Australia
MicroSeq® Workflow
or Sample from colony or pure culture
MicroSeq PCR module (1 reaction) < 2 hours
MicroSeq Cycle sequencing module (2 reactions) < 2 hours
MicroSeq analysis software and rDNA database < 30 minutes
Final identification report
PrepMan Ultra DNA isolation < 30 minutes
WM, Westmead Hospital, Sydney, Australia
The Future
DNA Extraction Robot Real Time PCR Sequencing
Extraction Detection Identification
WM, Westmead Hospital, Sydney, Australia
DNA Array Technology Small glass or silicon matrices on which potentially
thousands of short oligonucleotides can be immobilized
e.g. - species-specific DNA probes
- antifungal resistance genes
- virulence genes
Macroarray Microarray
C. glabrataC. parapsilopsisC. lipolyticaC. kruseiC. norvegensisC. lusitaniaeC. multigemmisC. tropicalisC. utilis
C. g
.
C. p
.
C. l
.
C. k
.
C. n
.
C. l
i.
C. m
.
C. t
.
C. u
.
WM, Westmead Hospital, Sydney, Australia
PCR Methods for Fungal IDMethod Culture Pattern Reproducibility Identification Turn- Cost
Requirements Stability Level around Efficiency Time
PCR-Amplification single colony very good very good species 1 days good
of Specific Genes tissue sample
PCR-RFLP single colony very good very good species 2 days good
Real Time PCR single colony very good very good species 1-2 hours good
PCR-Fingerprinting pure culture very good very good species/strain 2 days good
(RAPD/AFLP) (RAPD: good-poor)
Sequencing single colony/ best best species/strain/ 2 days expensive
tissue sample single mutation
Reference Labs only! Average Medical Mycology Lab
WM, Westmead Hospital, Sydney, Australia
PCR Assay Sensitivity
Multi-copy Genes:e.g. 18S rRNA 1-5 CFU
ITS 10 CFU/ml blood
Single-copy Genes:e.g. Actin 1-10 CFU
1.4- lanosterol demethylase 10-100 CFU/ml bloodHeat-shock protein 90 10-100 CFU
WM, Westmead Hospital, Sydney, Australia
Role of Molecular Diagnosis for Candidiasis
- Blood / Serum
+ve PCR good
Consecutive +ve PCR very good
- ve PCR cannot justify ceasing therapy
WM, Westmead Hospital, Sydney, Australia
Precautions for clinical PCR
Standard approaches for the three major phases of clinical PCR:
- Sample preparation- Target and probe selection- PCR and post-PCR analysis- Positive and negative controls
PCR contamination!!!
WM, Westmead Hospital, Sydney, Australia
Pitfalls of DNA based Identification
PCR reaction; contamination risk
e.g. Qiagen DNA extraction columns contaminated with fungal DNA
Detection of false positives or false negatives
Disease causing agent or colonization
WM, Westmead Hospital, Sydney, Australia
Sources of Contamination
Pre-PCR Contamination
No routine sample collection methods have been established for PCR-diagnosis
Contaminating DNA can originate from:
Any persons skin, hair, door handles, surfaces in the laboratory
Clinical equipment (maybe sterile but not DNA free)
Reagents Use only PCR grade!!
Taq polymerase (can contain procaryotic or eucaryotic DNA)
PCR components (e.g: gelatine, BSA)
PCR products from previous PCR reactions (e.g. if diagnostic PCR is repeatedly performed)
WM, Westmead Hospital, Sydney, Australia
Floor Plan for a Clinical PCR Laboratory
WM, Westmead Hospital, Sydney, Australia
Many in-house DNA based fungal ID techniques exist:
Problem all of them lack standardization
There is a lack of commercial interest to develop DNA based fungal ID systems, because of: - the limited market
- limited antifungal spectrum available
- high development costs
Commercially available DNA based ID kits exist only for:
- Blastomyces dermatitidis, Histoplasma capsulatum, Coccidioides immitis
(AccuProbe Kits, Gen-Probe, USA)
- Candida albicans (Roche)
- Universal Fungal ID via Sequencing MicroSeq (Applied Biosystems)
In summary, consistently reliable, universally applicable and standardized methods for fungal ID are still to be established.
WM, Westmead Hospital, Sydney, Australia
Acknowledgements
Molecular Mycology Laboratory Microbiogen/Macquarie University Krystyna Marszewska Dr. Phillip Bell
Mathew Huynh
Sarah Kidd CBS, The Netherlands
Dr. Nicolas G. Latouche Dr. Vincent Robert
Dr. Heide-Marie Daniel David Yarrow
Dr. Catriona L. Halliday
WM, Westmead Hospital, Sydney, Australia
Molecular Mycology Reference Laboratory
Samples Should be Directed to:Westmead Hospital
ICPMRDarcy Road
Westmead, NSW 2145
Marked: Molecular Mycology Laboratory
Contact Persons: Dr. Wieland Meyer Ph.: 61-2-98456895Fax: 61-2-98915317E-mail: [email protected]
More Info soon at: www.usyd.edu.au/~cidm